Tokio Marine Asset Management Co. Ltd. Raises Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Tokio Marine Asset Management Co. Ltd. raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 20.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 104,490 shares of the healthcare conglomerate's stock after purchasing an additional 17,815 shares during the period. UnitedHealth Group accounts for approximately 1.9% of Tokio Marine Asset Management Co. Ltd.'s holdings, making the stock its 9th biggest position. Tokio Marine Asset Management Co. Ltd.'s holdings in UnitedHealth Group were worth $52,857,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Capital Insight Partners LLC raised its position in UnitedHealth Group by 5.5% during the fourth quarter. Capital Insight Partners LLC now owns 9,247 shares of the healthcare conglomerate's stock valued at $4,678,000 after acquiring an additional 480 shares in the last quarter. Stableford Capital II LLC boosted its stake in UnitedHealth Group by 11.1% in the 4th quarter. Stableford Capital II LLC now owns 4,260 shares of the healthcare conglomerate's stock valued at $2,155,000 after buying an additional 426 shares in the last quarter. Abundance Wealth Counselors grew its stake in UnitedHealth Group by 5.0% during the fourth quarter. Abundance Wealth Counselors now owns 2,110 shares of the healthcare conglomerate's stock worth $1,067,000 after buying an additional 100 shares during the last quarter. Brio Consultants LLC acquired a new position in UnitedHealth Group in the fourth quarter worth $216,000. Finally, Independence Bank of Kentucky grew its stake in shares of UnitedHealth Group by 0.8% during the fourth quarter. Independence Bank of Kentucky now owns 10,675 shares of the healthcare conglomerate's stock valued at $5,400,000 after purchasing an additional 81 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm's stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.33% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. Piper Sandler cut their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Truist Financial reduced their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. Finally, UBS Group reduced their target price on UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating on the stock in a report on Wednesday, October 16th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Buy" and an average price target of $629.32.

UnitedHealth Group Stock Performance

UNH traded down $9.02 during midday trading on Wednesday, reaching $536.43. The company had a trading volume of 3,053,411 shares, compared to its average volume of 4,396,613. The stock has a market cap of $493.66 billion, a PE ratio of 34.66, a P/E/G ratio of 1.48 and a beta of 0.61. The business has a 50-day moving average price of $533.81 and a two-hundred day moving average price of $564.94. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group's revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the business earned $5.83 EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.